3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems

Journal of Controlled Release

Volumn 234, Issue , 2016, Pages 41-48

  Goyanes, Alvaro ^a   Det Amornrat, Usanee ^a   Wang, Jie ^a   Basit, Abdul W ^a,b   Gaisford, Simon ^a,b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b FABRX LTD   (United Kingdom)

Author keywords

Acne vulgaris; Additive manufacturing; Fused deposition modelling; Hot melt extrusion; Rapid prototyping; Stereolithography; Three dimensional printing

Indexed keywords

3D PRINTERS; CONTROLLED DRUG DELIVERY; DEPOSITION; DIFFUSION; ETHYLENE GLYCOL; EXTRUSION; LASER BEAMS; MELT SPINNING; POLYCAPROLACTONE; POLYETHYLENE GLYCOLS; POLYOLS; RAPID PROTOTYPING; SCANNING; STEREOLITHOGRAPHY; TARGETED DRUG DELIVERY;

3D PRINTING (3DP) TECHNOLOGY; ACNE VULGARIS; FUSED DEPOSITION MODELLING; HOT MELT EXTRUSION; INNOVATIVE TECHNOLOGY; POLYETHYLENE GLYCOL DIACRYLATE; SYNTHETIC MEMBRANES; TOPICAL DRUG DELIVERY SYSTEMS;

SALICYLIC ACID;

MACROGOL; POLYCAPROLACTONE; SALICYLIC ACID;

ARTICLE; CELL MEMBRANE; CLINICAL ASSESSMENT TOOL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; DRUG STABILITY; FUSED DEPOSITION MODELLING; LASER; MORPHOLOGICAL TRAIT; MORPHOLOGY; NANOFABRICATION; PRIORITY JOURNAL; STEREOLITHOGRAPHY; THREE DIMENSIONAL IMAGING; THREE DIMENSIONAL PRINTING; ACNE VULGARIS; CUTANEOUS DRUG ADMINISTRATION; FEASIBILITY STUDY; HUMAN; PERSONALIZED MEDICINE; PHARMACEUTICS; PROCEDURES; TRANSDERMAL PATCH;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; DRUG STABILITY; FEASIBILITY STUDIES; HUMANS; PRECISION MEDICINE; PRINTING, THREE-DIMENSIONAL; SALICYLIC ACID; TECHNOLOGY, PHARMACEUTICAL; TRANSDERMAL PATCH;

EID: 84975885806     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.05.034     Document Type: Article

References (26)

1. [1] Das, S., Reynolds, R.V., Recent advances in acne pathogenesis: implications for therapy. Am. J. Clin. Dermatol. 15 (2014), 479–488.
2. [2] Tan, J.K.L., Bhate, K., A global perspective on the epidemiology of acne. Br. J. Dermatol. 172:Suppl. 1 (2015), 3–12.
3. [3] Knutsen-Larson, S., Dawson, A.L., Dunnick, C.A., Dellavalle, R.P., Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol. Clin. 30 (2012), 99–106 (viii-ix).
4. [4] Nguyen, R., Su, J., Treatment of acne vulgaris. Paediatr. Child Health 21 (2011), 119–125.
5. [5] Ramanathan, S., Hebert, A.A., Management of acne vulgaris. J. Pediatr. Health Care 25 (2011), 332–337.
6. [6] Ventola, C.L., Medical applications for 3D printing: current and projected uses. Pharmacol. Ther. 39 (2014), 704–711.
7. [7] Goyanes, A., Wang, J., Buanz, A., Martinez-Pacheco, R., Telford, R., Gaisford, S., Basit, A.W., 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol. Pharm. 12 (2015), 4077–4084.
8. [8] Alomari, M., Mohamed, F.H., Basit, A.W., Gaisford, S., Personalised dosing: Printing a dose of one's own medicine. Int. J. Pharm., 494, 2015, 568.
9. [9] Gross, B.C., Erkal, J.L., Lockwood, S.Y., Chen, C., Spence, D.M., Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences. Anal. Chem. 86 (2014), 3240–3253.
10. [10] Water, J.J., Bohr, A., Boetker, J., Aho, J., Sandler, N., Nielsen, H.M., Rantanen, J., Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. J. Pharm. Sci. 104 (2015), 1099–1107.
11. [11] Salgado, C.L., Sanchez, E., Mano, J., Moraes, A., Characterization of chitosan and polycaprolactone membranes designed for wound repair application. J. Mater. Sci. 47 (2012), 659–667.
12. [12] Ulery, B.D., Nair, L.S., Laurencin, C.T., Biomedical applications of biodegradable polymers. J. Polym. Sci. B Polym. Phys. 49 (2011), 832–864.
13. [13] Patrício, T., Domingos, M., Gloria, A., Bártolo, P., Characterisation of PCL and PCL/PLA scaffolds for tissue engineering. Procedia CIRP 5 (2013), 110–114.
14. [14] Tyson, A.L., Hilton, S.T., Andreae, L.C., Rapid, simple and inexpensive production of custom 3D printed equipment for large-volume fluorescence microscopy. Int. J. Pharm. 494 (2015), 651–656.
15. [15] Wang, J., Goyanes, A., Gaisford, S., Basit, A.W., Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int. J. Pharm. 503 (2016), 207–212.
16. [16] Arcaute, K., Mann, B.K., Wicker, R.B., Stereolithography of three-dimensional bioactive poly(ethylene glycol) constructs with encapsulated cells. Ann. Biomed. Eng. 34 (2006), 1429–1441.
17. [17] Arcaute, K., Mann, B., Wicker, R., Stereolithography of spatially controlled multi-material bioactive poly(ethylene glycol) scaffolds. Acta Biomater. 6 (2010), 1047–1054.
18. [18] Melchels, F.P.W., Feijen, J., Grijpma, D.W., A review on stereolithography and its applications in biomedical engineering. Biomaterials 31 (2010), 6121–6130.
19. [19] Chan, V., Zorlutuna, P., Jeong, J.H., Kong, H., Bashir, R., Three-dimensional photopatterning of hydrogels using stereolithography for long-term cell encapsulation. Lab Chip 10 (2010), 2062–2070.
20. [20] Vehse, M., Petersen, S., Sternberg, K., Schmitz, K.-P., Seitz, H., Drug delivery from poly(ethylene glycol) diacrylate scaffolds produced by DLC based micro-stereolithography. Macromol. Symp. 346 (2014), 43–47.
21. [21] Fenner_Drives, Support technical specifications. http://www.ninjaflex3d.com/support/using-ninjaflex/technical-specifications/ (last accessed 04–2016).
22. [22] PPE_Ltd, A technical guide to elastomer compounds and chemical compatibility. http://www.prepol.com/Ppe-Uploads/Elastomer_guide_chemical_compatibility.pdf (last accessed 04–2016).
23. [23] Xu, L., Crawford, K., Gorman, C.B., Effects of temperature and pH on the degradation of poly(lactic acid) brushes. Macromolecules 44 (2011), 4777–4782.
24. [24] Goyanes, A., Buanz, A.B., Hatton, G.B., Gaisford, S., Basit, A.W., 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur. J. Pharm. Biopharm. 89 (2015), 157–162.
25. [25] Ng, S.-F., Rouse, J., Sanderson, D., Eccleston, G., A comparative study of Transmembrane diffusion and permeation of ibuprofen across synthetic membranes using Franz diffusion cells. Pharmaceutics 2 (2010), 209–223.
26. [26] Rhein, L., Chaudhuri, B., Jivani, N., Fares, H., Davis, A., Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation. J. Cosmet. Sci. 55 (2004), 65–80.